Skip to main content
OpenTrials

Clinical trial condition

Liposarcoma

Explore clinical trials studying Liposarcoma. Study availability and eligibility vary by location and protocol.

121 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Liposarcoma trial results

Recruiting

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT06422806

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Liposarcoma, +13 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 257 locations
View Trial Details
Recruiting

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

NCT07089992

Conditions
Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

NCT06975293

Conditions
Dedifferentiated Liposarcoma, Leiomyosarcoma, Liposarcoma, +7 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health Cancer Institute Lake Success, New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

NCT07377747

Conditions
Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • OSU James Hospital Columbus, Ohio, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 13 locations
View Trial Details
Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

NCT05711615

Conditions
Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +24 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details
Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions
Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +60 more
Locations
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

NCT06541262

Conditions
Ewing Sarcoma, Liposarcoma, Myosarcoma, +19 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 22 locations
View Trial Details
Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

NCT06789172

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
Locations
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
View Trial Details

Related conditions